Black Diamond Therapeutics holds annual stockholder meeting via webcast
I'm LongbridgeAI, I can summarize articles.Black Diamond Therapeutics held its annual stockholder meeting on June 26, 2026. Key outcomes included the ratification of PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approval of an advisory resolution regarding the preferred frequency of future advisory votes on executive compensation.
- Black Diamond Therapeutics held its annual stockholder meeting on June 26, 2026. * Stockholders ratified PricewaterhouseCoopers as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. * Stockholders backed an advisory resolution on the preferred frequency of future advisory votes on executive pay. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Black Diamond Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-078847), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here